Medimmune
  • ABOUT MEDIMMUNE
    • Key Facts & Figures
    • Products
    • Facilities
    • At the Forefront
  • OUR CULTURE
    • History & Highlights
    • Visionaries at MedImmune
    • Executive Team
    • Corporate Responsibility
  • R & D
    • Pipeline
    • Drug Phase Chart
    • Biologics
    • Technologies & Approaches
    • Partnering
  • VENTURES
    • Investing in Our Future
    • Portfolio
  • PRESS ROOM
  • CAREERS
  • CONTACT
  • Home >
    • News & Media

News and Media

For press releases:

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Receive E-mail alerts

Subscribe to RSS feeds

December 17, 2003
MedImmune to Study Therapeutic Benefit of Vitaxin(R) To Treat Prostate Cancer and Psoriasis
December 5, 2003
New Data Suggest That a Live Attenuated Influenza Vaccine May Induce Immunity Against Currently Circulating Drifted A/Fujian-Like Influenza Strain
December 4, 2003
It's Not Too Late to Vaccinate - As More People in the U.S. Succumb to the Flu Bug, the Time for Flu Protection is Now
November 20, 2003
MedImmune Demonstrates Proof of Principle for Targeting EphA2 Protein Overexpressed on Cancer Cells
November 17, 2003
MedImmune Provides Update on FluMist(TM) Launch and Revises Guidance for 2003 Fourth Quarter and Full Year
November 7, 2003
FluMist(TM) Recognized by Popular Science As 'Best of What's New' for 2003
October 23, 2003
MedImmune Reports Record Revenues for 2003 Third Quarter and Nine-Month Period
October 17, 2003
Wal-Mart Defers Establishing a National Flu Vaccination Program
October 13, 2003
Data From Phase 3 Studies With Next Generation Intranasal Influenza Vaccine Presented at International Conference
October 1, 2003
MedImmune Files Numax(TM) Investigational New Drug Application
September 30, 2003
MedImmune to Announce 2003 Third Quarter Financial Results on October 23, 2003
September 30, 2003
MedImmune Expands Intranasal Vaccine Program
September 16, 2003
FDA Approves Expanded Label for Synagis(R) Use In Children with Congenital Heart Disease (CHD)
September 10, 2003
FluMist(TM) Available in Pharmacies This Fall
September 9, 2003
MedImmune Initiates Two Phase 2 Clinical Trials for Vitaxin(R)
September 8, 2003
MedImmune Promotes Several Senior Executives and Appoints New Vice President, Oncology Sales & Marketing
September 2, 2003
FluMist(TM), First Intranasal Flu Vaccine in the U.S., Now Available From Health Care Providers
August 14, 2003
MedImmune Announces Addition of David Baltimore, Ph.D. To Board of Directors
August 7, 2003
MedImmune Amends Securities Trading Policy Pursuant to SEC Rule 10b5-1
July 31, 2003
MedImmune and Critical Therapeutics Enter Alliance to Co-Develop Treatments for Severe Inflammatory Diseases
July 24, 2003
MedImmune Reports Record Revenues for 2003 Six-Month Period and Second Quarter
July 10, 2003
Medimmune Announces Terms of $500 Million Of Convertible Senior Notes
July 9, 2003
MedImmune Announces Proposed $500 Million Convertible Notes Offering
July 9, 2003
MedImmune Announces $500 Million Stock Repurchase Program
June 27, 2003
MedImmune's Business Review Meeting to Provide Overview of Opportunities for Long-Term Growth
June 19, 2003
MedImmune Announces 2003 Business Review Meeting With Investors and Analysts
June 17, 2003
FDA Approves FluMist(TM) First Nasal Mist Influenza Vaccine Licensed in the U.S.
June 9, 2003
MedImmune and Micromet Sign Agreement to Co-Develop Treatment for B Cell Tumors
May 22, 2003
MedImmune Provides Update to Investors at 2003 Annual Shareholders' Meeting
April 30, 2003
Maryland Chamber of Commerce to Induct MedImmune's Dr. Hockmeyer Into Maryland Business Hall of Fame
April 24, 2003
MedImmune Reports Record Revenues and Net Earnings For First Quarter 2003
February 7, 2003
MedImmune Responds to FluMist(TM) Complete Response Letter
January 30, 2003
MedImmune Reports 2002 Fourth Quarter and Year-End Results
January 30, 2003
MedImmune Receives Complete Response Letter from FDA for FluMist(TM), an Intranasal Flu Vaccine
  • Terms and Conditions
  • |
  • Privacy Policy
  • |
  • Site Map
  • |
  • Contact Us
  • |
  • Glossary
Copyright © 2009 MedImmune, LLC. All rights reserved.